US FDA authorizes early access to Revolution's pancreatic cancer pill

The U.S. Food and Drug Administration has authorized the granting of early access before regulatory approval to Revolution ​Medicines' pill for patients with previously treated ‌pancreatic cancer, the company said on Friday.